MT-RNR1 and chronic obstructive pulmonary disease: Interestingly, concomitant T2DM resulted in no further reductions in circulating MOTS-c levels compared to patients with COPD alone; these results suggest that the effects of these two diseases on MOTS-c levels are not additive.